Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Australia's Immuron rises as full-year loss shrinks, revenue grows

** Shares of Immuron IMC.AX rise as much as 4.4% to A$0.072, their highest level since August 20

** The biopharmaceutical co's annual loss after income tax expense attributable shrinks to A$5.3 million ($3.38 million) from a loss of A$6.9 million last year

** Reports FY revenue of A$7.3 million from A$4.9 million a year ago

** Stock down 8.9% YTD, including the session's moves

($1 = 1.5389 Australian dollars)

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))

Recent news on Immuron

See all news